| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.01 | 1 |